Loading company…
Won a federal SBIR/STTR research award from NSF and other federal agencies.
Temprian Oncology Inc has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $275,000 in 2023. These are non-dilutive federal research grants, not equity financing. The company is based in Oak Park, Illinois.
1 round · latest STTR Phase I award (NSF), Dec 2023
Sign in to see 1 rounds.
Sign inNo investors recorded yet for Temprian Oncology Inc.
Add an investorTemprian Oncology Inc has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Temprian Oncology Inc.
Add diversity data